|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||
|
1. Title of Derivative Security | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock option (right to buy) | $4.8 | 03/18/2025 | D | 15,318 | (1) | 12/10/2028 | Class A Common Stock | 15,318 | (1) | 0 | D | ||||
Stock option (right to buy) | $2.2 | 03/18/2025 | A | 15,318 | (1) | 12/10/2028 | Class A Common Stock | 15,318 | (1) | 15,318 | D | ||||
Stock option (right to buy) | $10.68 | 03/18/2025 | D | 15,318 | (2) | 10/20/2027 | Class A Common Stock | 15,318 | (2) | 0 | D | ||||
Stock option (right to buy) | $8.08 | 03/18/2025 | A | 15,318 | (2) | 10/20/2027 | Class A Common Stock | 15,318 | (2) | 15,318 | D | ||||
Stock option (right to buy) | $11.43 | 03/18/2025 | D | 100,000 | (3) | 11/16/2031 | Class A Common Stock | 100,000 | (3) | 0 | D | ||||
Stock option (right to buy) | $8.83 | 03/18/2025 | A | 100,000 | (3) | 11/16/2031 | Class A Common Stock | 100,000 | (3) | 100,000 | D | ||||
Stock option (right to buy) | $7.1 | 03/18/2025 | D | 30,636 | (4) | 04/17/2034 | Class A Common Stock | 30,636 | (4) | 0 | D | ||||
Stock option (right to buy) | $4.5 | 03/18/2025 | A | 30,636 | (4) | 04/17/2034 | Class A Common Stock | 30,636 | (4) | 30,636 | D | ||||
Stock option (right to buy) | $7.45 | 03/18/2025 | D | 30,636 | (5) | 05/04/2033 | Class A Common Stock | 30,636 | (5) | 0 | D | ||||
Stock option (right to buy) | $4.85 | 03/18/2025 | A | 30,636 | (5) | 05/04/2033 | Class A Common Stock | 30,636 | (5) | 30,636 | D |
The reported transactions involve an amendment of an outstanding option to reduce the exercise price by $2.599553 per share, resulting in the deemed cancellation of the "old" option with respect to those shares and the grant of a replacement option. The option was originally granted on December 10, 2018 and provides for vesting in three equal annual installments beginning on the first anniversary of the grant date. | |
The reported transactions involve an amendment of an outstanding option to reduce the option exercise price by $2.599553 per share, resulting in the deemed cancellation of the "old" option with respect to those shares and the grant of a replacement option. The option was originally granted on October 20, 2017 and provides for vesting in three equal annual installments beginning on the first anniversary of the grant date. | |
The reported transactions involve an amendment of an outstanding option to reduce the option exercise price by $2.599553 per share, resulting in the deemed cancellation of the "old" option with respect to those shares and the grant of a replacement option. The option was originally granted on November 16, 2021 and provides for vesting in three equal annual installments beginning on the first anniversary of the grant date. | |
The reported transactions involve an amendment of an outstanding option to reduce the option exercise price by $2.599553 per share, resulting in the deemed cancellation of the "old" option with respect to those shares and the grant of a replacement option. The option was originally granted on April 17, 2024 and provides for vesting in three equal annual installments beginning on the first anniversary of the grant date. | |
The reported transactions involve an amendment of an outstanding option to reduce the option exercise price by $2.599553 per share, resulting in the deemed cancellation of the "old" option with respect to those shares and the grant of a replacement option. The option was originally granted on May 4, 2023 and provides for vesting in three equal annual installments beginning on the first anniversary of the grant date. |
Signatures | ||
/s/ Allen Sussman, Attorney-in-Fact | 03/24/2025 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |